SENORES Share Price Target 2050

CAGR-based price projection for Senores Pharmaceuticals Limited (SENORES) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (25.7% CAGR)
Rs 328,149
2050 Target
Base Case (64.3% CAGR)
Rs 202,215,283
2050 Target
Bull Case (220.9% CAGR)
Rs 1,926,069,479,576,852
2050 Target

Current Market Snapshot

CMP: Rs 1,349.60
52W High: Rs 1,550.90
52W Low: Rs 821.40
1Y CAGR: 170.0%
3Y CAGR: 64.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,697 Rs 2,217 Rs 4,332
2028 Rs 2,133 Rs 3,643 Rs 13,902
2029 Rs 2,682 Rs 5,986 Rs 44,618
2030 Rs 3,372 Rs 9,836 Rs 143,202
2031 Rs 4,239 Rs 16,161 Rs 459,606
2032 Rs 5,329 Rs 26,553 Rs 1,475,101
2033 Rs 6,700 Rs 43,627 Rs 4,734,323
2034 Rs 8,424 Rs 71,682 Rs 15,194,766
2035 Rs 10,590 Rs 117,776 Rs 48,767,461
2036 Rs 13,314 Rs 193,512 Rs 156,518,713
2037 Rs 16,739 Rs 317,950 Rs 502,345,353
2038 Rs 21,044 Rs 522,408 Rs 1,612,272,734
2039 Rs 26,458 Rs 858,341 Rs 5,174,574,328
2040 Rs 33,263 Rs 1,410,296 Rs 16,607,748,120
2041 Rs 41,819 Rs 2,317,185 Rs 53,302,412,943
2042 Rs 52,575 Rs 3,807,247 Rs 171,073,598,003
2043 Rs 66,099 Rs 6,255,491 Rs 549,059,119,795
2044 Rs 83,101 Rs 10,278,074 Rs 1,762,200,132,281
2045 Rs 104,476 Rs 16,887,374 Rs 5,655,764,915,386
2046 Rs 131,349 Rs 27,746,774 Rs 18,152,124,830,851
2047 Rs 165,134 Rs 45,589,293 Rs 58,259,075,616,532
2048 Rs 207,610 Rs 74,905,418 Rs 186,981,960,697,203
2049 Rs 261,011 Rs 123,073,232 Rs 600,116,861,728,048
2050 Rs 328,149 Rs 202,215,283 Rs 1,926,069,479,576,852

Other SENORES Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the SENORES share price target for 2050?

Based on historical growth analysis, the SENORES share price target for 2050 ranges from Rs 328,149 (conservative) to Rs 202,215,283 (base case) to Rs 1,926,069,479,576,852 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of SENORES?

The current market price of SENORES (Senores Pharmaceuticals Limited) is Rs 1,349.60. The 52-week high is Rs 1,550.90 and 52-week low is Rs 821.40.

Is SENORES a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for SENORES price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 25.7% CAGR), Base (64.3% CAGR), and Bull (optimistic at 220.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.